Adverse kidney events with initiation of SGLT2 inhibitors versus DPP4 inhibitors in diabetic people with a history of acute kidney injury

Documenti analoghi

• SGLT‐2 inhibitors for cardiac amyloidosis: Hype or hope?
  di: Flavio Tangianu, et al.
  Pubblicazione: (2025)
• Machine learning prediction of moderate‐to‐severe acute kidney injury after ICU admission and cardiac surgery with urine trace elements
  di: Yang Chen, et al.
  Pubblicazione: (2025)
• Type 2 diabetes and chronic kidney disease as long‐term predictors of cardiovascular events in patients with coronary artery disease
  di: Laura Schnetzer, et al.
  Pubblicazione: (2024)
• The glucagon‐like peptide‐1 receptor agonist semaglutide in diabetic kidney disease: A new kid on the block to afford maximal kidney protection
  di: Panagiotis I. Georgianos, et al.
  Pubblicazione: (2024)
• Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors
  di: Yi‐Wei Kao, et al.
  Pubblicazione: (2024)